Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 2)

v3.10.0.1
Summary of Significant Accounting Policies (Details 2) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Disaggregation of Revenue [Line Items]        
Sale of product $ 66 $ 160 $ 211 $ 369
QURR [Member]        
Disaggregation of Revenue [Line Items]        
Sale of product [1] 40 51 156 123
YOLKED [Member]        
Disaggregation of Revenue [Line Items]        
Sale of product [2] 13 28
Myos Canine Muscle Formula [Member]        
Disaggregation of Revenue [Line Items]        
Sale of product [3] 8 8
Physician Muscle Health Formula [Member]        
Disaggregation of Revenue [Line Items]        
Sale of product [4] 5 7 19 10
Cenegenics [Member]        
Disaggregation of Revenue [Line Items]        
Sale of product [5] 100 100
Egg Yolk Powder [Member]        
Disaggregation of Revenue [Line Items]        
Sale of product [6]     116
Re Muscle Health [Member]        
Disaggregation of Revenue [Line Items]        
Sale of product [6] $ 2 $ 20
[1] QURR product was launched in April 2017
[2] YOLKED product was launched in April 2018
[3] Myos Canine Muscle Formula was launched in June 2018
[4] Physician's Muscle Health Formula was launched in June 2016
[5] Cenegenics is a private label fortetropin based product we produce as ordered
[6] Egg Yolk Powder and Re Muscle Health products were no longer available after 2017